Study: Monoclonal antibody effective against atopic dermatitis | Hospitals don't always agree on pressure sores, study says | Scientists explore cell reprogramming for wound healing
August 9, 2017
Advanced Tissue SmartBrief
Your resource for current wound care information
Wound Care Update
Study: Monoclonal antibody effective against atopic dermatitis
Glenmark Pharmaceuticals announced a successful midstage clinical trial of a monoclonal antibody, GBR 830, for treatment of atopic dermatitis. The company said it would launch a Phase IIb trial early in 2018.
The Economic Times (India)/Press Trust of India (8/1) 
LinkedIn Twitter Facebook Google+ Email
Hospitals don't always agree on pressure sores, study says
A study in BMJ Quality and Safety found hospitals did not always agree on the definition of a pressure sore or the progression of one. Hospitals had the highest level of agreement when patients were transferred between acute care facilities and the lowest when patients transferred from a skilled nursing facility to an acute inpatient hospital.
MedPage Today (free registration) (8/4) 
LinkedIn Twitter Facebook Google+ Email
Research, Technology & Innovation
Scientists explore cell reprogramming for wound healing
Ohio State University scientists are investigating a wound-healing method in which a small computer chip placed on the wound site delivers programmed DNA or RNA cells into living skin cells through an electrical field. The tissue nanotransfection technique is expected to be in human trials by next year and may have potential against peripheral vascular disease.
ABC News (8/7) 
LinkedIn Twitter Facebook Google+ Email
Thin biomaterials could improve wound healing
Scientists at Northwestern University have developed thin flexible biomaterials, combining structural proteins from animal organs with polymers, that could be used for wound healing and regenerative medicine, as well as other applications. The processed material retains its biochemical and protein architecture, which stimulates cells to grow in specific ways, researchers said.
R&D Magazine online (8/7) 
LinkedIn Twitter Facebook Google+ Email
Wound-healing trials at Drexel to investigate ultrasound therapy
Researchers at Drexel University are developing a noninvasive treatment for chronic wounds that uses low-frequency ultrasound applied directly to the wound. Randomized, double-blinded clinical trials will take place over the next five years to verify the efficacy of the treatment and how it works on a cellular level, the Drexel researchers write in this commentary, a response to a report criticizing the lack of academic research for chronic wounds.
The Philadelphia Inquirer (8/4) 
LinkedIn Twitter Facebook Google+ Email
Other News
Health Policy & Regulation
Efforts to stabilize markets may not materialize in time for 2018
Although Congressional Republicans have said they want to take steps to stabilize the individual insurance market, concrete action could come too late. Insurers have spent months stressing the need for clarity on cost-sharing reduction payments and calling for other measures, but now Congress is out of town for a month, and in most states, health plans need to finalize rates in the next two weeks and finalize contracts for 2018 by the end of September.
Politico (8/4) 
LinkedIn Twitter Facebook Google+ Email
Learn more about ADVTIS:
Smart Pac Packaging | Placing an Order
Why Use Advanced Tissue | Home
Inspiration is never genuine if it is known as inspiration at the time. True inspiration always steals on a person.
Samuel Butler,
LinkedIn Twitter Facebook Google+ Email
About Advanced Tissue
Advanced Tissue is a leading wound care supply company offering a comprehensive line of wound care products from virtually all manufacturers. We understand the many obstacles associated with effective wound treatment and use this insight to provide the efficient delivery of dressings to enable enhanced compliance and improved patient outcomes.
Contact Advanced Tissue
7003 Valley Ranch Drive
Little Rock, Arkansas 72223
Sign Up
SmartBrief offers 200+ newsletters
Subscriber Tools:
Contact Us:
Editor  -  Kathryn Doherty
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information